ALX Oncology Holdings, Inc. (ALXO)
1.91
-0.13
(-6.37%)
USD |
NASDAQ |
Mar 30, 16:00
1.905
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings Total Assets (Quarterly) : 59.05M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.440B |
| Catalyst Pharmaceuticals, Inc. | 1.107B |
| ADMA Biologics, Inc. | 633.35M |
| Aldeyra Therapeutics, Inc. | 72.06M |
| Coherus Oncology, Inc. | 265.77M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 33.06M |
| Shareholders Equity (Quarterly) | 25.98M |
| Debt to Equity Ratio | 0.5685 |
| Current Ratio | 2.066 |
| Net Debt Paydown Yield | 0.84% |